HR 4263, the ADINA Act, requires drug manufacturers to clearly label human-use drugs containing major food allergens (like peanuts or shellfish) or ingredients derived from gluten-containing grains (such as wheat or barley). This affects drug producers and pharmacies by mandating that labels state the presence of these allergens and specify the exact gluten source if applicable. The law aims to inform consumers with allergies about potential risks in medications. It applies to all drugs meeting these criteria, with implementation beginning within two years of the bill's enactment.
HR 3595, the MORE USDA Grants Act, reduces local matching requirements by 50% for qualifying USDA grants for counties where over half the land is federally owned and population is under 100,000. It directly affects these "High-Density Public Land Counties" and their local governments or Tribal governments seeking USDA rural development funds. Key provisions include prioritizing applications from these areas in grant approvals, providing extra technical assistance during applications, and allowing flexibility for specific barriers like job-count scoring or partnership requirements that disadvantage small rural communities. The bill aims to make USDA grant programs more accessible to federally dominated rural areas facing financial or structural hurdles.
HR 3522, the FIRESHEDS Act, creates a new process for managing wildfire risks on federal lands by designating "fireshed management areas" in collaboration between the federal government and state governors. These areas - identified as landscape-scale regions facing the highest wildfire exposure - will be managed through joint assessments to prioritize projects like prescribed burns, fuel breaks, and hazardous fuels reduction, directly affecting communities in the wildland-urban interface. The bill streamlines environmental reviews for these projects (exempting them from NEPA requirements) and requires collaborative planning with local stakeholders, while prohibiting work in designated wilderness areas or on lands where timber harvesting is banned. It applies specifically to National Forest System lands and aims to accelerate wildfire risk reduction through existing federal authorities.
This joint resolution (SJRES 36) seeks congressional disapproval of a Department of Labor rule (88 Fed. Reg. 12842, March 1, 2023) that would have removed religious exemption provisions from the Equal Opportunity Clause requirements for federal contractors. If approved, it would prevent the rule from taking effect, meaning federal contractors would continue to be required to comply with the Equal Opportunity Clause without the religious exemption previously allowed. The bill directly affects federal contractors subject to the Office of Federal Contract Compliance Programs' (OFCCP) regulations. It is a procedural disapproval measure under Title 5, U.S. Code, not a new policy change.
This non-binding Senate resolution states that military action taken under NATO's mutual defense clause (Article 5) does not override Congress's constitutional duty to declare war before U.S. forces engage in hostilities. It clarifies that the President cannot use NATO obligations as justification for military action without prior Congressional authorization. The resolution directly addresses how NATO commitments interact with the Constitution's war powers requirement. As a formal Senate expression of opinion, it has no legal effect but aims to reinforce Congress's role in military decisions.
This resolution (SRES 272) commemorates the one-year anniversary of the U.S. Supreme Court's June 24, 2022, *Dobbs v. Jackson Women's Health Organization* decision, which overturned *Roe v. Wade*. It expresses the Senate's support for the Court's ruling that the Constitution does not guarantee a right to abortion and affirms the return of abortion regulation authority to state legislatures. The resolution celebrates the decision as a step toward protecting "unborn life" and commits to supporting families and "proclaiming the humanity of the unborn." As a non-binding resolution, it does not create new laws or affect any individuals directly.
HRES 536 is a ceremonial resolution designating the week of June 18-24, 2023, as "National Women's Sports Week." It celebrates the anniversary of Title IX (passed June 23, 1972), which prohibits sex discrimination in education and athletics. The resolution urges the House to observe this week through programs highlighting female athletes, coaches, and parents, while emphasizing equal athletic opportunities for women. It does not create new laws or alter existing policies - it is a symbolic gesture to recognize Title IX's impact on women's sports participation.
S 2210, the Iran Sanctions Relief Review Act, requires the President to submit a detailed report to Congress before terminating, waiving, or significantly altering U.S. sanctions on Iran. Congress then has 30 days (or 60 days during summer months) to review the proposal through committee hearings and decide whether to approve or disapprove it via joint resolution. During this review period, the President cannot implement the sanction change without Congressional approval. The bill directly affects the executive branch's ability to modify Iran sanctions policy and gives Congress formal oversight authority over major foreign policy shifts related to Iran.
This bill prohibits the Thrift Savings Plan (TSP), which serves federal employees and retirees, from offering investment funds that base decisions on environmental, social, and governance (ESG) criteria. It bans mutual funds or exchange-traded funds marketed using ESG factors - such as climate policies, diversity metrics, gun manufacturing ties, or political affiliations - from the TSP's investment options. The bill requires the TSP board to remove existing ESG-linked funds within 90 days of enactment and gives participants 90 days to switch their investments to other TSP funds, with unselected funds automatically moving to a government securities fund. The law directly affects federal employees' retirement savings by restricting their investment choices based on ESG considerations.
The 21st Century Worker Act establishes a new classification system for service providers, determining whether they are employees or independent contractors under federal law. It creates specific criteria for mandatory classification (such as substantial economic relationships for employees or licensed professions for independent contractors) and allows some service providers to elect their classification with written agreements requiring counter-signatures from service recipients. The bill amends key federal laws including the Fair Labor Standards Act and tax code to align with these new definitions, imposing penalties for non-compliance with classification requirements. This affects workers and businesses across various industries who provide services for compensation, changing how they're treated under labor and tax laws. The legislation also requires a GAO study to identify other federal laws that need to be updated to match these new definitions.
Protect Drug Innovation Act This bill repeals several programs and requirements that were enacted under the Inflation Reduction Act of 2022 relating to the prices of prescription drugs, including (1) the Medicare Drug Price Negotiation Program, (2) provisions that require drug manufacturers to issue rebates for certain drugs under Medicare for which prices increase faster than inflation, and (3) provisions that cap annual out-of-pocket spending under the Medicare prescription drug benefit.
This bill clarifies that human cadaveric islet transplants (cells from deceased donors used in diabetes treatment) are not classified as "drugs," "biological products," or "HCT/Ps" under existing federal law. It amends the Public Health Service Act to explicitly include "human cadaveric islets" in regulatory references, ensuring these transplants are not subject to the same oversight as pharmaceuticals or other biological products. The bill requires the Health Secretary to update relevant regulations within one year of enactment and report progress to Congress within six months. This change directly affects how the FDA and other agencies regulate islet transplants, streamlining their approval process without altering medical practice.
